Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
75%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Active, not recruiting1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (75.0%)
N/A1 (25.0%)

Trials by Status

unknown125%
active_not_recruiting125%
withdrawn125%
completed125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_2

Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers

NCT06216366
unknownphase_2

Hyperbaric Radiation Sensitization of Head and Neck Cancers

NCT03843671
completednot_applicable

Effects of High-Intensity Interval Training (HIT) While in a Hyperoxic-Hyperbaric Environment on Exercise Performance

NCT02941939
withdrawnphase_2

Effect of Repeated Exposures to Compressed Air on Patients With AIDS

NCT00444847

Clinical Trials (4)

Showing 4 of 4 trials
NCT06216366Phase 2

Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers

Active Not Recruiting
NCT03843671Phase 2

Hyperbaric Radiation Sensitization of Head and Neck Cancers

Unknown
NCT02941939Not Applicable

Effects of High-Intensity Interval Training (HIT) While in a Hyperoxic-Hyperbaric Environment on Exercise Performance

Completed
NCT00444847Phase 2

Effect of Repeated Exposures to Compressed Air on Patients With AIDS

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4